Search filters

List of works by Jessika Bertacchini

A-type lamins and signaling: the PI 3-kinase/Akt pathway moves forward

scientific article published on September 2009

An interaction study in mammalian cells demonstrates weak binding of HSPB2 to BAG3, which is regulated by HSPB3 and abrogated by HSPB8.

scientific article

Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit

scientific article published on 22 November 2018

Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis.

scientific article

Inhibition of Ras-mediated signaling pathways in CML stem cells.

scientific article published on 12 October 2015

Lamin A Ser404 is a nuclear target of Akt phosphorylation in C2C12 cells

scientific article published on 23 September 2008

Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression

scientific article

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.

scientific article published on 7 May 2007

Proposal of a Novel Natural Biomaterial, the Scleral Ossicle, for the Development of Vascularized Bone Tissue In Vitro.

scientific article published on 25 December 2017

Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

scientific article published on 6 November 2015

Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia

scientific article published on 2 December 2010

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.

scientific article published on 22 November 2015

Targeting PI3K/AKT/mTOR network for treatment of leukemia.

scientific article

The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.

scientific article

Paulina is supported by:

About Paulina

Help